688266 澤璟製藥
按盤價 
51.480 -0.830 (-1.587%) | 2024/03 - 人民幣(K¥) | 與去年末期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 0 | -- | 0 | 0 | 0 | 0 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 0 |
| 固定資產 | 95,022 | -3.32% | 98,289 | 109,214 | 99,212 | 81,954 |
| 在建工程 | 154,688 | 13.89% | 135,827 | 86,673 | 27,245 | 9,072 |
| 無形資產 | 64,378 | -7.06% | 69,270 | 91,030 | 116,291 | 129,514 |
| 商譽 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動資產 | 67,666 | 6.59% | 63,485 | 89,639 | 97,257 | 80,175 |
| 381,754 | 4.06% | 366,871 | 376,556 | 340,005 | 300,714 | |
流動資產 | ||||||
| 貨幣資金 | 1,989,125 | -5.71% | 2,109,641 | 797,047 | 1,136,632 | 1,149,734 |
| 應收賬款 | 112,023 | 10.76% | 101,140 | 88,985 | 62,371 | 0 |
| 存貨 | 130,431 | 17.66% | 110,852 | 98,978 | 51,911 | 23,138 |
| 其他流動資產 | 491,416 | 147.31% | 198,703 | 306,745 | 155,043 | 496,696 |
| 2,722,994 | 8.04% | 2,520,336 | 1,291,755 | 1,405,956 | 1,669,568 | |
流動負債 | ||||||
| 短期借款 | 953,387 | 19.90% | 795,165 | 390,793 | 131,809 | 17,670 |
| 應付票據 | 0 | -- | 0 | 0 | 0 | 0 |
| 應付帳款 | 122,208 | -11.27% | 137,735 | 151,721 | 118,191 | 64,957 |
| 其他流動負債 | 132,595 | -34.45% | 202,282 | 186,671 | 130,894 | 58,250 |
| 1,208,190 | 6.43% | 1,135,181 | 729,186 | 380,893 | 140,877 | |
| 流動資產淨值 | 1,514,804 | 9.36% | 1,385,155 | 562,569 | 1,025,063 | 1,528,691 |
| 資產總額減流動負債 | 1,896,558 | 8.25% | 1,752,026 | 939,126 | 1,365,068 | 1,829,405 |
非流動負債 | ||||||
| 長期借款 | 0 | -- | 0 | 50,094 | 0 | 30,034 |
| 應付債券 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動負債 | 295,846 | 176.00% | 107,189 | 101,545 | 111,987 | 107,781 |
| 295,846 | 176.00% | 107,189 | 151,639 | 111,987 | 137,815 | |
總權益 | ||||||
| 實收股本 | 264,708 | 0.00% | 264,708 | 240,000 | 240,000 | 240,000 |
| 儲備項目 | 1,328,985 | -2.86% | 1,368,145 | 519,118 | 956,323 | 1,377,725 |
| 股東權益 | 1,593,694 | -2.40% | 1,632,853 | 759,118 | 1,196,323 | 1,617,725 |
| 非控股權益 | 7,018 | -41.44% | 11,984 | 28,368 | 56,759 | 73,864 |
| 備註： | 即時報價更新時間為 03/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
